Sulfonylureas [35], which lower blood glucose by stimulating insulin secretion, and thiazolidinediones [36], which act as insulin sensitizers by binding to PPAR-γ receptors, are similarly not commonly associated with intestinal obstruction. Here, INS is linked to intestinal obstruction.